Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.2608 | 1 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.2608 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.1057 | 0.0855 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.2608 | 1 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.2608 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2608 | 1 | 0.5 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.2608 | 1 | 1 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.2608 | 1 | 0.5 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.2608 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CTS (functional) | = 4.9 | Calcitonin (CT) secretion/RIA assay to measure the ability of compound to increase cellular levels and secretion of human CT. | ChEMBL. | 10737755 |
Rolipram activity (binding) | = 0 % | PDE4 30 assay to measure the percent rolipram activity of the PDE4 assay at 30 microM concentrationof the compound. | ChEMBL. | 10737755 |
Rolipram activity (binding) | = 0 % | PDE4 30 assay to measure the percent rolipram activity of the PDE4 assay at 30 microM concentrationof the compound. | ChEMBL. | 10737755 |
TAR (functional) | = 2 | CT-luci reporter gene assay to measure the ability to increase transcription of a luciferase receptor gene linked to the human CT gene. | ChEMBL. | 10737755 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.